These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The determination of the thermal threshold in subjects with Raynaud's disease. A preliminary report of 2 clinical cases]. Luca S; Romeo S Minerva Cardioangiol; 1999 Jun; 47(6):213-7. PubMed ID: 10522147 [TBL] [Abstract][Full Text] [Related]
5. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon. Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Raynaud's phenomenon. García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160 [TBL] [Abstract][Full Text] [Related]
7. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon. Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542 [TBL] [Abstract][Full Text] [Related]
9. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases. Rychlik-Golema W; Mastej K; Adamiec R Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543 [TBL] [Abstract][Full Text] [Related]
15. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients. Pistorius MA; Planchon B; de Faucal P Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791 [TBL] [Abstract][Full Text] [Related]
20. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil. Seishima M; Izumi T; Kanoh H Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]